QT
ZVRA icon

Quantbot Technologies’s Zevra Therapeutics ZVRA Stock Holding History

Quantbot Technologies’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.69K Buy
+718
New +$6.47K ﹤0.01% 1562
2025
Q4 		– Sell
-62,646
Closed -$596K – 2246
2025
Q3 		$596K Buy
62,646
+33,654
+116% +$338K 0.02% 958
2025
Q2 		$255K Buy
+28,992
New +$235K 0.01% 1163
2025
Q1 		– Sell
-13,024
Closed -$109K – 1946
2024
Q4 		$109K Sell
13,024
-7,219
-36% -$61.6K ﹤0.01% 1184
2024
Q3 		$140K Buy
+20,243
New +$137K 0.01% 1105
2023
Q3 		– Sell
-4,900
Closed -$25K – 2035
2023
Q2 		$25K Buy
+4,900
New +$26.4K ﹤0.01% 1397
2021
Q2 		– Sell
-200
Closed -$1K – 1935
2021
Q1 		$1K Buy
+200
New +$1.75K ﹤0.01% 1351

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return